• Call :+91-11-2688 8181 / 46152728
  • English
  • French
  • Spanish
Thyroid Peroxidase IgG Elisa Test Kit
Pack Size :
96 Well
MRP :
` 10600/-
Our Price :
` 8480/-
Check delivery estimate for your pincode

Description

Pack Size : 96 Well

Package Kit Components :

  • Microwells coated
  • Sample Diluent
  • Calibrator
  • Positive Control
  • Negative Control
  • Enzyme conjugate
  • TMB Reagent
  • Stop Solution:
  • Wash Concentrate
  • Technical Insert

Usage : The New Life Thyroid Peroxidase (TPO) IgG ELISA Kit is intended for the detection of IgG antibody to Thyroid Peroxidase in human serum or plasma.

Description : Thyroid peroxidase (TPO), is the major autoantigen (933 amino acid residue) in the thyroid microsomal antigen (TMA) particle. The purification and preparation of this antigen has made testing for TMA antibodies obsolete. Assays for TPO antibodies include ELISA, precipitation of radiolabeled TPO-bound autoantibodies with protein A, competition for TPO binding to immobilized anti-TPO murine monoclonal antibodies, autoantibody capture by TPO-coated beads and chemiluminescence. All tests correlate well with detection of TMA. ELISA using TPO recombinant antigen is the most popular assay.  Detection of TPO antibodies is strong evidence against a goiter or non-autoimmune causes of hypothyroidism. The annual risk for the development of hypothyroidism is 3% to 4% per year if TPO antibodies are present and TSH is elevated. TPO antibodies are present in 8-9% normal controls, 57-74% patients with Graves disease, 99- 100% of Hashimoto disease or idiopathic myxedema, 19% with differentiated thyroid cancer, no patients with subacute thyroiditis and 11% of those with other miscellaneous non-autoimmune thyroid diseases. The prevalence of positive TPO antibodies is higher in elderly (mean age 80 years) women (10%) compared to elderly men (2%). Autoantibody concentration in centenarians also decreases.  Studies of TPO epitopes in each domain, A and B, and detection of their specific autoantibodies suggest that the epitope-specific TPO antibodies ratio (A/B) does not change over time in individual patients and that TPO epitope autoantibody patterns may be inherited.